Generic Aralen – Lariago (Chloroquine) Ipca Laboratories Ltd
€44.00
| Active substance |
Chloroquine |
|---|---|
| Water Retention |
Minimal to none |
| Hepatotoxicity |
Rare, but possible in cases of long-term use |
| Lab Test |
Blood concentrations can be monitored, though not commonly done |
| Also known as |
Chloroquine phosphate, Aralen |
| Blood pressure |
Usually does not affect blood pressure significantly |
| Trade name |
Aralen, Chloroquine Phosphate |
| Storage conditions |
Store at room temperature away from moisture and light |
| Chemical name |
7-Chloro-4-[(4-diethylamino-1-methylbutyl)amino]quinoline |
| Formula |
C18H26ClN3 |
| Substance class |
Aminoquinoline |
| Main action |
Antimalarial, antirheumatic |
| Half-life |
Approximately 1 to 2 months |
| Dosage (medical) |
Typically 500 mg weekly for malaria prophylaxis, and 250 mg daily for rheumatic diseases |
| Dosage (sports) |
Not applicable |
| Effects |
Prevention and treatment of malaria, and management of autoimmune disorders like rheumatoid arthritis and lupus |
| Side effects |
Retinopathy, muscle weakness, seizure, hearing loss, nausea, vomiting |
| Use in sports |
Not typically used in sports |
| Manufacturer |
Ipca Laboratories Ltd |
| Packing |
30 tabs |
Reviews
There are no reviews yet.